ClinicalTrials.Veeva

Menu

SoftStitch™ for All-Inside Meniscal Repair: Comparative Analysis of Patient Reported Outcome Measures

Arthrex logo

Arthrex

Status

Not yet enrolling

Conditions

Meniscus Tear

Treatments

Device: SoftStitch™

Study type

Observational

Funder types

Industry

Identifiers

NCT05491564
AIRR-0065

Details and patient eligibility

About

Acute and traumatic knee meniscus tears are a frequent occurrence. Evidence shows meniscal repair results in more favorable patient reported outcomes and articular cartilage preservation.1 This prospective, multicenter, single cohort, longitudinal study is intended to evaluate the effectiveness and safety profile of SoftStitch™ when used as standard of care for All-Inside Meniscal Repair. Electronic Patient Reported Outcome Measures (ePROM), functional assessments of the knee, Adverse Events of interest and Adverse Device Effects will be assessed.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Confirmed meniscal tear by physical exam and MRI (minimum 1.5T)
  2. Recommended to undergo surgical intervention using SoftStitch™ for All-Inside meniscus repair of longitudinal tears on the posterior horn that a surgeon would traditionally repair with two or more all-inside devices, as standard of care
  3. Normal mechanical alignment; < 5° varus and < 7° valgus, of the affected knee by clinical assessment or X-Rays
  4. Male or female, ≥ 18 years old and ≤55
  5. Provide written informed consent
  6. Able and willing to participate in follow up visits
  7. Have a valid email and internet access to receive and respond to ePROs throughout the study

Exclusion criteria

  1. Meniscal tears which are not amendable to repair, such as degenerative, flap, radial, complex, etc.
  2. ACL-injured knees that are unstable (concomitant ACL reconstruction OK to include)
  3. Sensitivity to silicone, polyester, nylon, FD&C Blue No. 2 dye and beeswax
  4. Blood supply limitations and previous or active6, joint or systemic, infections which may decrease healing
  5. Skeletally immature defined as patients with open epiphyseal plates viewed on radiographs
  6. Concomitant disease that would interfere with study outcomes
  7. Congenital ligamentous hypermobility defined by Beighton score 4 or 5
  8. Locked knee or haemarthrosis7
  9. Mutiligament injuries requiring multiligament surgical stabilization
  10. Concomitant hybrid meniscal repair techniques or devices
  11. Advanced Osteoarthritis; Kellgren Lawrence ≥ 2
  12. Fracture of the lower extremities within 6 months prior to screening
  13. Previous surgery on the affected knee within 12 months prior to screening
  14. Subject is included in a vulnerable population (child, prisoner, etc).
  15. Subject is requesting or receiving Worker's compensation related to the knee injury
  16. Inability to reply to online questionnaires because of mental impairment
  17. Participation in another clinical investigation in the next two years

Trial contacts and locations

0

Loading...

Central trial contact

Alicia Ruiz; Justin W Moss, DHSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems